Bildkälla: Stockfoto

Active Biotech: Positive Phase I Results - Redeye

Redeye raises its Base Case slightly following the positive conclusion of the phase I trial with laquinimod.

Redeye raises its Base Case slightly following the positive conclusion of the phase I trial with laquinimod.
Börsvärldens nyhetsbrev
ANNONSER